Works by Scheiner, Bernhard

Results: 76
    1

    Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis.

    Published in:
    Journal of Hepatocellular Carcinoma, 2025, v. 12, p. 855, doi. 10.2147/JHC.S511263
    By:
    • Munker, Stefan;
    • Rodriguez, Isaac;
    • Bernhart, Kathrin;
    • Khaled, Najib Ben;
    • Findik, Merve;
    • Siegmund, Lisa Katrin;
    • Ye, Liangtao;
    • Reiter, Florian P;
    • Roessler, Daniel;
    • Nasseh, Daniel;
    • Balcar, Lorenz;
    • Pomej, Katharina;
    • Scheiner, Bernhard;
    • Weiss, Christel;
    • Pinter, Matthias;
    • Seidensticker, Max;
    • Mayerle, Julia;
    • Philipp, Alexander B;
    • De Toni, Enrico N
    Publication type:
    Article
    2

    Non‐Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1‐Negative Myeloproliferative Neoplasms.

    Published in:
    Liver International, 2025, v. 45, n. 6, p. 1, doi. 10.1111/liv.70098
    By:
    • Balcar, Lorenz;
    • Degenfeld‐Schonburg, Lina;
    • Hopp, Can;
    • Kramer, Georg;
    • Graf, Irene;
    • Simonis, Lucie;
    • Sillaber, Christian;
    • Kalteis, Stephanie;
    • Gisslinger, Heinz;
    • Meischl, Tobias;
    • Stättermayer, Albert Friedrich;
    • Mandorfer, Mattias;
    • Mitterbauer‐Hohendanner, Gerlinde;
    • Reiberger, Thomas;
    • Trauner, Michael;
    • Scheiner, Bernhard;
    • Krauth, Maria‐Theresa;
    • Semmler, Georg
    Publication type:
    Article
    3

    ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.

    Published in:
    Journal of Hepatocellular Carcinoma, 2025, v. 12, p. 671, doi. 10.2147/JHC.S462701
    By:
    • Stefanini, Bernardo;
    • Fulgenzi, Claudia Angela Maria;
    • Scheiner, Bernhard;
    • Korolewicz, James;
    • Cheon, Jaekyung;
    • Nishida, Naoshi;
    • Ang, Celina;
    • Marron, Thomas U;
    • Wu, Y Linda;
    • Saeed, Anwaar;
    • Wietharn, Brooke;
    • Rimassa, Lorenza;
    • Pirozzi, Angelo;
    • Cammarota, Antonella;
    • Pressiani, Tiziana;
    • Pinter, Matthias;
    • Balcar, Lorenz;
    • Huang, Yi-Hsiang;
    • Mehan, Aman;
    • Phen, Samuel
    Publication type:
    Article
    4

    Letter: The Prognostic Role of IGF‐1 in Chronic Liver Disease—Authors' Reply.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 228, doi. 10.1111/apt.18368
    By:
    • Hartl, Lukas;
    • Schwarz, Michael;
    • Simbrunner, Benedikt;
    • Jachs, Mathias;
    • Wolf, Peter;
    • Bauer, David Josef Maria;
    • Scheiner, Bernhard;
    • Balcar, Lorenz;
    • Semmler, Georg;
    • Hofer, Benedikt Silvester;
    • Dominik, Nina;
    • Marculescu, Rodrig;
    • Trauner, Michael;
    • Mandorfer, Mattias;
    • Reiberger, Thomas
    Publication type:
    Article
    5

    Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 1, p. 88, doi. 10.1111/apt.18289
    By:
    • Hartl, Lukas;
    • Schwarz, Michael;
    • Simbrunner, Benedikt;
    • Jachs, Mathias;
    • Wolf, Peter;
    • Bauer, David Josef Maria;
    • Scheiner, Bernhard;
    • Balcar, Lorenz;
    • Semmler, Georg;
    • Hofer, Benedikt Silvester;
    • Dominik, Nina;
    • Marculescu, Rodrig;
    • Trauner, Michael;
    • Mandorfer, Mattias;
    • Reiberger, Thomas
    Publication type:
    Article
    6

    Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1497, doi. 10.1111/apt.18324
    By:
    • Dominik, Nina;
    • Balcar, Lorenz;
    • Semmler, Georg;
    • Simbrunner, Benedikt;
    • Schwarz, Michael;
    • Hofer, Benedikt S.;
    • Hartl, Lukas;
    • Jachs, Mathias;
    • Scheiner, Bernhard;
    • Pinter, Matthias;
    • Trauner, Michael;
    • Mandorfer, Mattias;
    • Pilger, Alexander;
    • Reiberger, Thomas
    Publication type:
    Article
    7
    8
    9

    Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 11, p. 1376, doi. 10.1111/apt.17945
    By:
    • Dominik, Nina;
    • Scheiner, Bernhard;
    • Zanetto, Alberto;
    • Balcar, Lorenz;
    • Semmler, Georg;
    • Campello, Elena;
    • Schwarz, Michael;
    • Paternostro, Rafael;
    • Simbrunner, Benedikt;
    • Hofer, Benedikt S.;
    • Stättermayer, Albert Friedrich;
    • Pinter, Matthias;
    • Trauner, Michael;
    • Quehenberger, Peter;
    • Simioni, Paolo;
    • Reiberger, Thomas;
    • Mandorfer, Mattias
    Publication type:
    Article
    10
    11

    Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 71, doi. 10.1111/apt.17507
    By:
    • Semmler, Georg;
    • Scheiner, Bernhard;
    • Balcar, Lorenz;
    • Paternostro, Rafael;
    • Simbrunner, Benedikt;
    • Pinter, Matthias;
    • Trauner, Michael;
    • Bofill Roig, Marta;
    • Meyer, Elias Laurin;
    • Hofer, Benedikt Silvester;
    • Mandorfer, Mattias;
    • Pinato, David James;
    • Zauner, Christian;
    • Reiberger, Thomas;
    • Funk, Georg‐Christian
    Publication type:
    Article
    12
    13

    Sequential systemic treatment in patients with hepatocellular carcinoma.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 205, doi. 10.1111/apt.15789
    By:
    • Kirstein, Martha M.;
    • Scheiner, Bernhard;
    • Marwede, Tristan;
    • Wolf, Caroline;
    • Voigtländer, Torsten;
    • Semmler, Georg;
    • Wacker, Frank;
    • Manns, Michael P.;
    • Hinrichs, Jan B.;
    • Pinter, Matthias;
    • Vogel, Arndt
    Publication type:
    Article
    14
    15
    16

    Programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 10, p. 1323, doi. 10.1111/apt.15245
    By:
    • Scheiner, Bernhard;
    • Schwabl, Philipp;
    • Waneck, Fredrik;
    • Reiberger, Thomas;
    • Müller, Christian;
    • Sieghart, Wolfgang;
    • Trauner, Michael;
    • Pinter, Matthias;
    • Kirstein, Martha M.;
    • Hinrichs, Jan B.;
    • Vogel, Arndt;
    • Hucke, Florian;
    • Peck‐Radosavljevic, Markus;
    • Finkelmeier, Fabian;
    • Waidmann, Oliver;
    • Trojan, Jörg;
    • Schulze, Kornelius;
    • von Felden, Johann;
    • Wege, Henning;
    • Koch, Sandra
    Publication type:
    Article
    17
    18
    19

    Clinical course of congestive hepatopathy pre/post heart transplantation.

    Published in:
    Wiener Klinische Wochenschrift, 2024, v. 136, n. 9/10, p. 267, doi. 10.1007/s00508-023-02231-2
    By:
    • Balcar, Lorenz;
    • Semmler, Georg;
    • Scheiner, Bernhard;
    • Stättermayer, Albert Friedrich;
    • Ćosić, Stefan;
    • Schwabl, Philipp;
    • Kazem, Niema;
    • Mandorfer, Mattias;
    • Hülsmann, Martin;
    • Zuckermann, Andreas;
    • Reiberger, Thomas
    Publication type:
    Article
    20

    Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).

    Published in:
    Wiener Klinische Wochenschrift, 2023, v. 135, p. 493, doi. 10.1007/s00508-023-02229-w
    By:
    • Mandorfer, Mattias;
    • Aigner, Elmar;
    • Cejna, Manfred;
    • Ferlitsch, Arnulf;
    • Datz, Christian;
    • Gräter, Tilmann;
    • Graziadei, Ivo;
    • Gschwantler, Michael;
    • Hametner-Schreil, Stephanie;
    • Hofer, Harald;
    • Jachs, Mathias;
    • Loizides, Alexander;
    • Maieron, Andreas;
    • Peck-Radosavljevic, Markus;
    • Rainer, Florian;
    • Scheiner, Bernhard;
    • Semmler, Georg;
    • Reider, Lukas;
    • Reiter, Silvia;
    • Schoder, Maria
    Publication type:
    Article
    21
    22

    Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221080298
    By:
    • de Castro, Tiago;
    • Jochheim, Leonie S.;
    • Bathon, Melanie;
    • Welland, Sabrina;
    • Scheiner, Bernhard;
    • Shmanko, Kateryna;
    • Roessler, Daniel;
    • Khaled, Najib Ben;
    • Jeschke, Matthias;
    • Ludwig, Johannes M.;
    • Marquardt, Jens U.;
    • Weinmann, Arndt;
    • Pinter, Matthias;
    • Lange, Christian M.;
    • Vogel, Arndt;
    • Saborowski, Anna
    Publication type:
    Article
    23

    Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma.

    Published in:
    Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2024, v. 29, n. 6, p. 1, doi. 10.1016/j.aohep.2024.101534
    By:
    • Stern, Louisa;
    • Schmidt, Constantin;
    • Kocheise, Lorenz;
    • Joerg, Vincent;
    • Casar, Christian;
    • Walter, Aurélie;
    • Drenth, Joost P. H.;
    • Papp, Maria;
    • Gatselis, Nikolaos K.;
    • Zachou, Kalliopi;
    • Pinter, Matthias;
    • Scheiner, Bernhard;
    • Vogel, Arndt;
    • Kirstein, Martha M.;
    • Finkelmeier, Fabian;
    • Waidmann, Oliver;
    • Weinmann, Arndt;
    • Milkiewicz, Piotr;
    • Thorburn, Douglas;
    • Halliday, Neil
    Publication type:
    Article
    24
    25
    26
    27
    28

    High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2904, doi. 10.1111/liv.16056
    By:
    • Schwarz, Michael;
    • Simbrunner, Benedikt;
    • Jachs, Mathias;
    • Hartl, Lukas;
    • Balcar, Lorenz;
    • Bauer, David J. M.;
    • Semmler, Georg;
    • Hofer, Benedikt S.;
    • Scheiner, Bernhard;
    • Pinter, Matthias;
    • Stättermayer, Albert F.;
    • Trauner, Michael;
    • Reiberger, Thomas;
    • Mandorfer, Mattias
    Publication type:
    Article
    29
    30

    Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.

    Published in:
    Liver International, 2023, v. 43, n. 3, p. 695, doi. 10.1111/liv.15502
    By:
    • Talbot, Thomas;
    • D'Alessio, Antonio;
    • Pinter, Matthias;
    • Balcar, Lorenz;
    • Scheiner, Bernhard;
    • Marron, Thomas U.;
    • Jun, Tomi;
    • Dharmapuri, Sirish;
    • Ang, Celina;
    • Saeed, Anwaar;
    • Hildebrand, Hannah;
    • Muzaffar, Mahvish;
    • Fulgenzi, Claudia A. M.;
    • Amara, Suneetha;
    • Naqash, Abdul Rafeh;
    • Gampa, Anuhya;
    • Pillai, Anjana;
    • Wang, Yinghong;
    • Khan, Uqba;
    • Lee, Pei‐Chang
    Publication type:
    Article
    31

    Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.

    Published in:
    Liver International, 2022, v. 42, n. 11, p. 2501, doi. 10.1111/liv.15365
    By:
    • Simbrunner, Benedikt;
    • Villesen, Ida Falk;
    • Königshofer, Philipp;
    • Scheiner, Bernhard;
    • Bauer, David;
    • Paternostro, Rafael;
    • Schwabl, Philipp;
    • Timelthaler, Gerald;
    • Ramazanova, Dariga;
    • Wöran, Katharina;
    • Stift, Judith;
    • Eigenbauer, Ernst;
    • Stättermayer, Albert Friedrich;
    • Marculescu, Rodrig;
    • Pinter, Matthias;
    • Møller, Søren;
    • Trauner, Michael;
    • Karsdal, Morten;
    • Leeming, Diana Julie;
    • Reiberger, Thomas
    Publication type:
    Article
    32
    33

    Safety of direct oral anticoagulants in patients with advanced liver disease.

    Published in:
    Liver International, 2021, v. 41, n. 9, p. 2159, doi. 10.1111/liv.14992
    By:
    • Semmler, Georg;
    • Pomej, Katharina;
    • Bauer, David J. M.;
    • Balcar, Lorenz;
    • Simbrunner, Benedikt;
    • Binter, Teresa;
    • Hartl, Lukas;
    • Becker, Jeannette;
    • Pinter, Matthias;
    • Quehenberger, Peter;
    • Trauner, Michael;
    • Mandorfer, Mattias;
    • Lisman, Ton;
    • Reiberger, Thomas;
    • Scheiner, Bernhard
    Publication type:
    Article
    34
    35

    Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.

    Published in:
    Liver International, 2020, v. 40, n. 7, p. 1713, doi. 10.1111/liv.14498
    By:
    • Simbrunner, Benedikt;
    • Marculescu, Rodrig;
    • Scheiner, Bernhard;
    • Schwabl, Philipp;
    • Bucsics, Theresa;
    • Stadlmann, Alexander;
    • Bauer, David J. M.;
    • Paternostro, Rafael;
    • Eigenbauer, Ernst;
    • Pinter, Matthias;
    • Stättermayer, Albert Friedrich;
    • Trauner, Michael;
    • Mandorfer, Mattias;
    • Reiberger, Thomas;
    • Hernandez‐Gea, Virginia
    Publication type:
    Article
    36
    37

    Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.

    Published in:
    Liver International, 2020, v. 40, n. 2, p. 393, doi. 10.1111/liv.14304
    By:
    • Scheiner, Bernhard;
    • Stättermayer, Albert F.;
    • Schwabl, Philipp;
    • Bucsics, Theresa;
    • Paternostro, Rafael;
    • Bauer, David;
    • Simbrunner, Benedikt;
    • Schmidt, Ralf;
    • Marculescu, Rodrig;
    • Ferlitsch, Arnulf;
    • Peck‐Radosavljevic, Markus;
    • Pinter, Mathias;
    • Trauner, Michael;
    • Reiberger, Thomas;
    • Ferenci, Peter;
    • Mandorfer, Mattias;
    • Bureau, Christophe
    Publication type:
    Article
    38
    39
    40
    41
    42

    Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.

    Published in:
    Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 12, p. 2164, doi. 10.1111/jgh.14700
    By:
    • Semmler, Georg;
    • Simbrunner, Benedikt;
    • Scheiner, Bernhard;
    • Schwabl, Philipp;
    • Paternostro, Rafael;
    • Bucsics, Theresa;
    • Stättermayer, Albert Friedrich;
    • Bauer, David;
    • Pinter, Matthias;
    • Ferenci, Peter;
    • Trauner, Michael;
    • Mandorfer, Mattias;
    • Reiberger, Thomas
    Publication type:
    Article
    43
    44
    45

    Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.

    Published in:
    Cancers, 2022, v. 14, n. 23, p. 5966, doi. 10.3390/cancers14235966
    By:
    • Sinner, Friedrich;
    • Pinter, Matthias;
    • Scheiner, Bernhard;
    • Ettrich, Thomas Jens;
    • Sturm, Niklas;
    • Gonzalez-Carmona, Maria A.;
    • Waidmann, Oliver;
    • Finkelmeier, Fabian;
    • Himmelsbach, Vera;
    • De Toni, Enrico N.;
    • Ben Khaled, Najib;
    • Mohr, Raphael;
    • Fründt, Thorben Wilhelm;
    • Kütting, Fabian;
    • Bömmel, Florian van;
    • Lieb, Sabine;
    • Krug, Sebastian;
    • Bettinger, Dominik;
    • Schultheiß, Michael;
    • Jochheim, Leonie S.
    Publication type:
    Article
    46

    Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

    Published in:
    Cancers, 2022, v. 14, n. 23, p. 5834, doi. 10.3390/cancers14235834
    By:
    • Wu, Yue Linda;
    • Fulgenzi, Claudia Angela Maria;
    • D'Alessio, Antonio;
    • Cheon, Jaekyung;
    • Nishida, Naoshi;
    • Saeed, Anwaar;
    • Wietharn, Brooke;
    • Cammarota, Antonella;
    • Pressiani, Tiziana;
    • Personeni, Nicola;
    • Pinter, Matthias;
    • Scheiner, Bernhard;
    • Balcar, Lorenz;
    • Huang, Yi-Hsiang;
    • Phen, Samuel;
    • Naqash, Abdul Rafeh;
    • Vivaldi, Caterina;
    • Salani, Francesca;
    • Masi, Gianluca;
    • Bettinger, Dominik
    Publication type:
    Article
    47
    48

    The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.

    Published in:
    Cancers, 2022, v. 14, n. 1, p. 186, doi. 10.3390/cancers14010186
    By:
    • Muhammed, Ambreen;
    • Fulgenzi, Claudia Angela Maria;
    • Dharmapuri, Sirish;
    • Pinter, Matthias;
    • Balcar, Lorenz;
    • Scheiner, Bernhard;
    • Marron, Thomas U.;
    • Jun, Tomi;
    • Saeed, Anwaar;
    • Hildebrand, Hannah;
    • Muzaffar, Mahvish;
    • Navaid, Musharraf;
    • Naqash, Abdul Rafeh;
    • Gampa, Anuhya;
    • Ozbek, Umut;
    • Lin, Junk-Yi;
    • Perone, Ylenia;
    • Vincenzi, Bruno;
    • Silletta, Marianna;
    • Pillai, Anjana
    Publication type:
    Article
    49

    Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma.

    Published in:
    Cancers, 2020, v. 12, n. 12, p. 3830, doi. 10.3390/cancers12123830
    By:
    • Spahn, Stephan;
    • Roessler, Daniel;
    • Pompilia, Radu;
    • Gabernet, Gisela;
    • Gladstone, Beryl Primrose;
    • Horger, Marius;
    • Biskup, Saskia;
    • Feldhahn, Magdalena;
    • Nahnsen, Sven;
    • Hilke, Franz J.;
    • Scheiner, Bernhard;
    • Dufour, Jean-François;
    • De Toni, Enrico N.;
    • Pinter, Matthias;
    • Malek, Nisar P.;
    • Bitzer, Michael
    Publication type:
    Article
    50